CONMED (NYSE:CNMD) Raised to Hold at StockNews.com
StockNews.com upgraded shares of CONMED (NYSE:CNMD – Free Report) from a sell rating to a hold rating in a report issued on Wednesday. Several other analysts have also recently commented on CNMD. KeyCorp boosted their price target on CONMED from $131.00 to $141.00 and gave the stock an overweight rating in a research report on […]
More Stories
Western Battery Technology Aims to Leapfrog China’s Mineral Dominance
By Owen Evans China’s stranglehold on the battery market could be loosened with emerging technology that substitutes hard-to-source minerals with...
Pumpkin Power: Boost Immunity, Regulate Blood Sugar, and Protect Eye Health
By Ellen Wan Pumpkin is rich in functional ingredients and nutrients and offers many potential health benefits. Both scientific research...
GAMMA Investing LLC Raises Position in Eaton Corporation, PLC (NYSE:ETN)
GAMMA Investing LLC raised its position in Eaton Corporation, PLC (NYSE:ETN – Free Report) by 0.7% during the 1st quarter,...
Bristol Myers Squibb Company (NYSE:BMY) Shares Sold by Spire Wealth Management
Spire Wealth Management reduced its position in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 1.6% in...
Golden State Wealth Management LLC Acquires 974 Shares of Zoetis Inc. (NYSE:ZTS)
Golden State Wealth Management LLC increased its holdings in Zoetis Inc. (NYSE:ZTS – Free Report) by 90.6% in the first...
Zoetis Inc. (NYSE:ZTS) Shares Sold by Bessemer Group Inc.
Bessemer Group Inc. decreased its stake in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 42.6% during the 1st...